Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR
Phase 3
Completed
- Conditions
- Healthy
- Registration Number
- NCT00668460
- Lead Sponsor
- Sanofi
- Brief Summary
The purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Pocket BR.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 52
Inclusion Criteria
- Phototype Skin I,II, III e IV
- Integral skin test in the region
Exclusion Criteria
- Lactation or gestation
- Use of Antiinflammatory and/or immunosuppression drugs
- Personnel history of atopy
- History of sensitivity or irritation for topic products
- Active cutaneous disease
- Use of new drugs or cosmetics during the study
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The absence of primary and accumulated dermal irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale. six weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-aventis administrative office
🇧🇷São Paulo, Brazil